These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29477727)

  • 1. Role of lipid mediators and control of lymphocyte responses in type 2 immunopathology.
    Samuchiwal SK; Boyce JA
    J Allergy Clin Immunol; 2018 Apr; 141(4):1182-1190. PubMed ID: 29477727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoids as regulators of innate and adaptive immunity.
    Hirata T; Narumiya S
    Adv Immunol; 2012; 116():143-74. PubMed ID: 23063076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis.
    Honda T; Kabashima K
    Int Immunol; 2019 Aug; 31(9):589-595. PubMed ID: 30715370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukotrienes: immune-modulating lipid mediators of disease.
    Di Gennaro A; Haeggström JZ
    Adv Immunol; 2012; 116():51-92. PubMed ID: 23063073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of critical pediatric asthma.
    Galowitz S; Chang C
    Clin Rev Allergy Immunol; 2015 Feb; 48(1):84-96. PubMed ID: 24452844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological Regulation by Bioactive Lipids].
    Taketomi Y; Murakami M
    Yakugaku Zasshi; 2017; 137(5):503-515. PubMed ID: 28458280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.
    Rusznak M; Peebles RS
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):38-45. PubMed ID: 30516547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosanoids: an emerging role in dendritic cell biology.
    Harizi H; Gualde N
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):1-5. PubMed ID: 15053227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory Pathways in the Pathogenesis of Asthma.
    Peebles RS; Aronica MA
    Clin Chest Med; 2019 Mar; 40(1):29-50. PubMed ID: 30691715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.
    White AA; Doherty TA
    Am J Rhinol Allergy; 2018 Jan; 32(1):7-11. PubMed ID: 29336282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-regulation and -functions of eicosanoid lipid mediators.
    Esser-von Bieren J
    Biol Chem; 2017 Oct; 398(11):1177-1191. PubMed ID: 28622139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
    van Rijt L; von Richthofen H; van Ree R
    Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I.
    Sokolowska M; Rovati GE; Diamant Z; Untersmayr E; Schwarze J; Lukasik Z; Sava F; Angelina A; Palomares O; Akdis CA; O'Mahony L; Sanak M; Dahlen SE; Woszczek G
    Allergy; 2021 Jan; 76(1):114-130. PubMed ID: 32279330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
    Harizi H; Gualde N
    Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
    Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA
    J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of leukotriene B(4) in allergic diseases.
    Ohnishi H; Miyahara N; Gelfand EW
    Allergol Int; 2008 Dec; 57(4):291-8. PubMed ID: 18797182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease.
    Moore BB; Peters-Golden M
    Expert Rev Clin Immunol; 2006 Jan; 2(1):87-100. PubMed ID: 20477090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3 major types of innate and adaptive cell-mediated effector immunity.
    Annunziato F; Romagnani C; Romagnani S
    J Allergy Clin Immunol; 2015 Mar; 135(3):626-35. PubMed ID: 25528359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.
    Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM
    J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.